您所在的位置:
作者:任燕红
单位:Capital Medical University

摘要

Introduction & Background

After cerebral ischemia, lactate accumulation in astrocytes may limit mitochondrial transfer to injured neurons and thereby exacerbate neuronal energy deficits. We therefore developed AS1–Ru–MnCO₃/LOx, an astrocyte-targeted nanozyme designed to promote lactate oxidation and reduce oxidative stress. This study aimed to determine whether the nanozyme could enhance astrocyte-to-neuron mitochondrial transfer and improve neuronal energy metabolism after cerebral ischemia.

Methods

Ru-doped manganese carbonate (Ru–MnCO₃) was loaded with lactate oxidase (LOx) and functionalized with the astrocyte-targeting peptide AS1. The nanozyme was characterized by transmission electron microscopy (TEM), dynamic light scattering (DLS), and X-ray photoelectron spectroscopy (XPS). Catalytic activity was measured using assay kits.

After oxygen–glucose deprivation/reoxygenation (OGD/R), astrocytes were assessed for mitochondrial membrane potential (JC-1), intracellular ROS (DCFH-DA), mitochondrial superoxide (MitoSOX), and apoptosis. In OGD/R-treated astrocyte–neuron co-cultures, we tracked astrocyte-derived mitochondria through tunneling nanotubes (TNTs) and measured MFN2, OPA1, and DRP1 expression, oxygen consumption rate (OCR), and extracellular acidification rate (ECAR).

In mice that underwent transient middle cerebral artery occlusion (tMCAO), ischemic brain lactate levels, mitochondrial ultrastructure (TEM), and neurological function were assessed. Brain injury was evaluated by Nissl and TTC staining and NeuN, MAP2, and PSD95 immunostaining.

 Results

AS1–Ru–MnCO₃/LOx was synthesized and characterized (TEM, DLS, XPS) and exhibited CAT- and SOD-like activities.

AS1–Ru–MnCO₃/LOx attenuated mitochondrial depolarization and apoptosis and lowered intracellular ROS and mitochondrial superoxide levels in OGD/R-treated astrocytes. In OGD/R-treated co-cultures, astrocyte-derived mitochondria were visualized within TNTs. Treatment increased astrocyte-to-neuron mitochondrial transfer and improved co-culture bioenergetics. It also increased MFN2 and OPA1 expression and decreased DRP1 expression, consistent with a shift toward mitochondrial fusion.

In tMCAO mice, AS1–Ru–MnCO₃/LOx lowered ischemic brain lactate levels, reduced infarct volume, and improved neurological function. TEM revealed less mitochondrial swelling and ultrastructural damage, and histology showed better preservation of neuronal structure.

Conclusions

AS1–Ru–MnCO₃/LOx improved neuronal energy metabolism and reduced ischemic brain injury in tMCAO mice, supporting its therapeutic potential for ischemic stroke.


相关会议

更多
“医”路携手,“药”有作为一基层抗感染系列学术研讨会(3)
2026-11-30
北京
重庆市医师协会器官移植医师分会2026年学术年会
2026-11-30
待定

相关直播

更多
第八届上海国际癌症大会
2026-06-03
上海静安英迪格酒店
观看回放
产前咨询
2026-09-01
产前咨询
观看回放
阜外医院心内科及相关学科系列讲座-老龄化时代:外周动脉疾病诊疗的机遇与挑战
2026-11-16
阜外医院心内科及相关学科系列讲座
观看回放

最新视频

更多
外固定下肢重建临床指导下的新型骨针及张力可调节系统研制
秦泗河
国家康复辅具研究中心附属康复医院
下腰椎肿瘤整块切除技术难点
严望军
复旦大学附属肿瘤医院
数智技术驱动老年脆性骨折诊疗研究
张里程
中国人民解放军总医院第四医学中心
增强型体外反搏联合空心螺钉固定促进股骨颈骨折愈合:一项前瞻性随机对照试验
王欣
武汉大学中南医院